AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04986514 — intervention group
Intervention type: OTHER
Intervention: Bio-banking without genetic analysis
Description: For patients included in SCLERO-BIOBANK study, 2 blood samples will be collected at each SSc evaluation (usually once a year), in addition to the routine care blood collection.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 1.1 Usage
Description: Participants will use Radicle Rest Active Product 1.1 as directed for a period of 6 weeks.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 1.2 Usage
Description: Participants will use Radicle Rest Active Product 1.2 as directed for a period of 6 weeks.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 2.1 Usage
Description: Participants will use Radicle Rest Active Product 2.1 as directed for a period of 6 weeks.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 2.2 Usage
Description: Participants will use Radicle Rest Active Product 2.2 as directed for a period of 6 weeks.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 1
Description: Participants will use Placebo Control Form 1 as directed for a period of 6 weeks.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 2
Description: Participants will use Placebo Control Form 2 as directed for a period of 6 weeks.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 3
Description: Participants will use Placebo Control Form 3 as directed for a period of 6 weeks.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 3.1 Usage
Description: Participants will use Radicle Rest Active Product 3.1 as directed for a period of 6 weeks.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Control Form 4
Description: Participants will use Placebo Control Form 4 as directed for a period of 6 weeks.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 4.1 Usage
Description: Participants will use Radicle Rest Active Product 4.1 as directed for a period of 6 weeks.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 4.2 Usage
Description: Participants will use Radicle Rest Active Product 4.2 as directed for a period of 6 weeks.
Study NCT05657808 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Rest Study Active Product 4.3 Usage
Description: Participants will use Radicle Rest Active Product 4.3 as directed for a period of 6 weeks.
Study NCT05290285 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Amino-Ther Pro
Description: Food supplements
Study NCT05290285 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Maltodextrin
Study NCT05998057 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: Exercises:~Lunge to Hamstrings Stretch 3 sets of 30 seconds~* Standing Hip Out 3 sets of 30sec~* 90-90 Hip Stretch 3 sets of 30 seconds~* World's Greatest Stretch 3 sets of 30 seconds~* Star Excursion 3 sets of 5 reps~* Side Jumps+ Balance 3 sets of 10 reps~* Forward Hops + Balance 3 sets of 10 reps~* Squat 3 sets of 10 reps~* Squat Jump 3 sets of 10 reps~* Jumping Spider Push-up 3 sets of 10 reps~* Double Leg Vertical Jump 3 sets of 10 reps~* Broad Jumps 3 sets of 10 reps~* Lateral Box Shuffles 3 sets of 10 reps~* Plank 3 sets of 30 seconds~* Side Plank 3 sets of 30 seconds~* Bird Dog 3 sets of 10 reps~* Glute Bridge 3 sets of 10 reps~* Single Leg Glute Bridge 3 sets of 10 reps~* Single Toe Raises 3 sets of 30sec~* Nordic Hamstrings 3 sets of 10 reps~* Monster Walk 3 sets of 10 reps
Study NCT05998057 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: The control group was asked to continue the standard (routine) classical training training (5 days/12 weeks).
Study NCT04265105 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fluticasone-vilanterol
Description: LABA-ICS combination Inhaled Long acting Beta agonist and inhaled corticosteroid
Study NCT04265105 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard Preparation
Description: inhaled SABA or Inhaled corticosteroid
Study NCT04944199 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical Activity
Description: Intervention group participants will be enrolled in a standardized step-based program to gradually increase their physical activity. Daily steps will be measured via a pedometer application on a smartphone or wearable device, with a gradual increase in the goal on a weekly basis, with a target intervention of around 4-6 weeks in total. The first week's step count will be used to calculate a baseline step count for the week. At the start of each week, the participants will be asked to increase their daily step counts by 1,000.
Study NCT06262126 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Virtual Reality
Description: Virtual Reality therapy
Study NCT04016766 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile app prepartying intervention
Description: The intervention is comprised of a theoretically-informed and empirically-supported, brief, accessible, and personalized intervention to address prepartying drinking. the prepartying intervention app will be tailored toward an individual's personal goals, beliefs (perceptions, expectancies, self-efficacy), and behavior (protective strategies), and focus on the core components of brief interventions that have been cited as constructs that mediate the effects of multiple component intervention programs (e.g., correcting perceived norms, use of protective behavioral strategies, increased self-efficacy, challenging expectancies, feedback on blood alcohol level).
Study NCT04923282 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: single 1-hour IV infusion of 0.8 mg/kg recAP
Description: Intravenous infusion
Study NCT04923282 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: single 1-hour IV infusion of 1.6 mg/kg recAP
Description: Intravenous infusion
Study NCT04923282 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: single 1-hour IV infusion of 3.2 mg/kg recAP
Description: Intravenous infusion
Study NCT04923282 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: 1-hour infusions of 1.6 mg/kg recAP on Days 1, 2 and 3
Description: Intravenous infusion
Study NCT04923282 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Intravenous infusion
Study NCT04660565 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone and Belimumab
Description: Prednisone/prednisolone: started at 0.6-0. 8mg/kg.d for 2 to 4 weeks, tapered at 5mg per 1-2 weeks to equal to or less than 5mg per day in 3 months. Belimumab will start at the same time as the prednisone induction.
Study NCT04660565 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Prednisone/prednisolone: started at 0.6-0. 8mg/kg.d for 2 to 4 weeks, tapered at 5mg per 1-2 weeks to equal to or less than 5mg per day in 3 months.
Study NCT05675969 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Blood sample
Description: Collection of 2 additional tubes of 4.5mL of citrate blood
Study NCT05675969 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: Collection of 2 additional tubes of 4.5mL of citrate blood
Study NCT06237504 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SaCoVLM™
Description: Patients will receive general anesthesia with their airways maintained with the SaCoVLM, which is a newer supraglottic airway device with a video port to directly visualize the upper airway.
Study NCT06237504 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ambu®Auragain™
Description: Patients will receive general anesthesia with their airways maintained with the Ambu Auragain, which is a conventional 2nd generation supraglottic airway device.
Study NCT05013541 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Observational study, standard record of need to void during cystometry
Study NCT05927155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LABA
Description: Inhalation of 4 puffs of 2,5 µg of a long-acting beta2-agonist (LABA-olodaterol) administered via a spacer device
Study NCT05927155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LAMA
Description: Inhalation of 4 puffs of 2,5 µg of a long-acting muscarinic antagonist (LAMA-tiotropium) administered via a spacer device
Study NCT05895812 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deuremidevir Hydrobromide Tablets
Description: JT001 single dose, 0.3g
Study NCT05349071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylprednisolone
Description: a single preoperative dose of 500 mg of methylprednisolone diluted in 250 mL of physiological saline 2 hours before surgery as a 30-minute infusion.
Study NCT05349071 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: physiological saline
Description: a single preoperative dose of 250 mL of physiological saline 2 hours before surgery as a 30-minute infusion.
Study NCT06422897 — intervention group
Intervention type: OTHER
Intervention: anterior segment optical coherence tomography
Description: surgically treated corneal perforation by amniotic membrane graft and platelet rich plasma clot is assessed by anterior segment optical coherence tomography 1 month postoperative
Study NCT05605886 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Solvazinc 50mg
Description: Patients will receive a daily zinc supplement tablets of 50 mg in the morning after breakfast for 4 days prior to injections.
Study NCT05605886 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT05548322 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Different surfaces to be touched
Description: The participant will touch various different surfaces and textures, including ones of different temperature and including solids and liquids.
Study NCT05548322 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotional state change
Description: The emotional state of the participant will be modulated by listening to music.
Study NCT05548322 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Description: The participant will receive electrical stimulation of single nerve fibers (a few microamps) to artificially excite an individual afferent.
Study NCT05465252 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Krill Oil 500 MG
Description: Qualified subjects start to take supplementation from Day 1 in the trial. Specifically, subjects from Intervention group take 3 capsules of krill oil per day.
Study NCT05465252 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Olive Oil 500MG
Description: Qualified subjects start to take placebo from Day 1 in the trial. Specifically, subjects from placebo group take 3 capsules of olive oil , which has the same color and smell as the krill oil.
Study NCT06403332 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: brief intervention
Description: The intervention for cohort A (intervention arm) based on brief intervention on alcohol consumption performed by a psycologist, medical visit peformed by an hepatologist including assessment of underlying liver disease with non invasive test (i.e Fibroscan and lab work).
Study NCT05785676 — intervention group
Intervention type: DEVICE
Intervention: Filter implantation
Description: Implantation of OATF ALN vena cava filter
Study NCT04780997 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: Microsoft Xbox Kinect® was used for virtual reality exercises
Study NCT05268913 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI scan
Description: Participants will undertake a magnetic resonance imaging scan.
Study NCT05268913 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood test
Description: Participants will undertake a fasting blood test.
Study NCT05751603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sugammadex
Description: sugammadex is administered just after extubation
Study NCT04752904 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ClearSight System
Description: Non-invasive, continuous blood pressure is monitored using ClearSight Sytem
Study NCT05612828 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conventional versus simulation manikin training
Description: Two approaches to training Combat Life Savers will be employed and performance of participants will be evaluated.
Study NCT05895019 — intervention group
Intervention type: DRUG
Intervention: Propofol
Description: Propofol was administered using TCI pump induction with a starting target effect concentration of 1.0ug/ml. The target concentration was increased by 0.2-0.5ug/ml if the patient did not reach unconsciousness after 1 min of stabilization of the target concentration. The propofol concentration recorded at this time was the target concentration the patient was induced to unconsciousness. The state of consciousness was tested every 60 s by the investigator, and clinical trial data were collected for 5 min; after that, clinical trial data were recorded before and after induction of anesthesia at 5 min after induction of anesthesia, at intubation and skin dissection, and 1, 3, and 5 min after intubation and skin dissection, respectively.
Study NCT05289895 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: This study was an observational trial without any intervention
Study NCT05334212 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surgical Theater
Description: The surgical theater platform uses data from MRI and CT scans, creating a 3d image that can be seen by the patient.
Study NCT04972617 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: albumin function analysis (ABIC)
Description: After centrifugation (10 minutes at 4000 rpm), the plasma is aliquoted and stored at minus 80° C until further analysis. The free as well as the total furosemide concentration is determined by HPLC. In addition to the characterisation of the albumin function by means of the ABiC, these samples can also be used for the determination of the albumin concentration (prerequisite for the determination of the ABiC) and free furosemide concentration as well as for the determination of further parameters relevant for the albumin function.
Study NCT05071248 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VEMO (Reactive Robotics GmbH)
Description: The robot used for early mobilization is able to verticalize the patients in their bed without transfer and to generate a movement of the legs that measures and supports the patients' own movement. The device meets the requirements for mobilizing critically ill patients in an intensive care unit, maintaining hygiene standards and providing the best possible support for the patient's own movement.
Study NCT05028244 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: venous ultrasound of lower extremity
Description: Patients are explored for deep vein thrombosis in femoral-popliteal and distal veins of the legs with ultrasound compression and doppler flow evaluation
Study NCT05425940 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XL092
Description: Supplied as tablets; administered orally daily
Study NCT05425940 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Supplied as 1200 mg/20 mL vials; administered as a 1200 mg IV infusion once in a 3-week cycle (q3w)
Study NCT05425940 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Regorafenib
Description: Supplied as 40 mg tablets; administered orally daily at 160 mg for the first 21 days of each 28-day cycle
Study NCT06223165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Floreciendo (Foundations, Condoms & Contraception, Family Strengthening, and Gender & Relationships)
Description: * Foundations in sexual risk prevention: Covers key topics in sexual and reproductive health and helps participants develop an awareness of sexual behavior risks.~* Condoms and contraception: Teaches about different forms of condoms and contraception and offers experiential activities on how to use them.~* Family strengthening: Facilitates learning and practice in how teens and their female caregivers can communicate about sex and addresses family norms and expectations in Latino culture.~* Gender and relationships: Covers what a healthy relationship looks like and how to recognize intimate partner violence, while discussing how gender and cultural norms in Latino culture influence teens' sexual behavior.
Study NCT06223165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Floreciendo (Foundations, Condoms & Contraception, and Family Strengthening)
Description: * Foundations in sexual risk prevention: Covers key topics in sexual and reproductive health and helps participants develop an awareness of sexual behavior risks.~* Condoms and contraception: Teaches about different forms of condoms and contraception and offers experiential activities on how to use them.~* Family strengthening: Facilitates learning and practice in how teens and their female caregivers can communicate about sex and addresses family norms and expectations in Latino culture.
Study NCT06223165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Floreciendo (Foundations, Condoms & Contraception, Gender & Relationships)
Description: * Foundations in sexual risk prevention: Covers key topics in sexual and reproductive health and helps participants develop an awareness of sexual behavior risks.~* Condoms and contraception: Teaches about different forms of condoms and contraception and offers experiential activities on how to use them.~* Gender and relationships: Covers what a healthy relationship looks like and how to recognize intimate partner violence, while discussing how gender and cultural norms in Latino culture influence teens' sexual behavior.
Study NCT06223165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Floreciendo (Foundations, Family Strengthening, and Gender & Relationships)
Description: * Foundations in sexual risk prevention: Covers key topics in sexual and reproductive health and helps participants develop an awareness of sexual behavior risks.~* Family strengthening: Facilitates learning and practice in how teens and their female caregivers can communicate about sex and addresses family norms and expectations in Latino culture.~* Gender and relationships: Covers what a healthy relationship looks like and how to recognize intimate partner violence, while discussing how gender and cultural norms in Latino culture influence teens' sexual behavior.
Study NCT06223165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Floreciendo (Foundations and Condoms & Contraception)
Description: * Foundations in sexual risk prevention: Covers key topics in sexual and reproductive health and helps participants develop an awareness of sexual behavior risks.~* Condoms and contraception: Teaches about different forms of condoms and contraception and offers experiential activities on how to use them.
Study NCT06223165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Floreciendo (Foundations and Family Strengthening)
Description: * Foundations in sexual risk prevention: Covers key topics in sexual and reproductive health and helps participants develop an awareness of sexual behavior risks.~* Family strengthening: Facilitates learning and practice in how teens and their female caregivers can communicate about sex and addresses family norms and expectations in Latino culture.
Study NCT06223165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Floreciendo (Foundations and Gender & Partner Relationships)
Description: * Foundations in sexual risk prevention: Covers key topics in sexual and reproductive health and helps participants develop an awareness of sexual behavior risks.~* Gender and relationships: Covers what a healthy relationship looks like and how to recognize intimate partner violence, while discussing how gender and cultural norms in Latino culture influence teens' sexual behavior.
Study NCT06223165 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Floreciendo (Foundations)
Description: • Foundations in sexual risk prevention: Covers key topics in sexual and reproductive health and helps participants develop an awareness of sexual behavior risks.
Study NCT05493800 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIT-001
Description: Corresponding dose of MIT-001 IV injection during 0.5\~1hr
Study NCT05493800 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: normal saline IV injection
Study NCT05136950 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Secondary in-the-bag IOL fixation
Description: The experimental group with secondary IOL fixated in the capsular bag
Study NCT05136950 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Secondary ciliary sulcus IOL fixation
Description: The control group with secondary IOL fixated in the ciliary sulcus